Previously, GFAP and MT3 have been linked to trauma, ischemia, and neurodegenerative diseases, including encephalomyelitis, multiple sclerosis, Parkinson’s disease, Alexander disease, Alzheimer’s disease, and amyotrophic lateral sclerosis.21 Here, MT3 is linked to Parkinson disease.